Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Plastic Chemicals May Increase Risk of High Blood Pressure: Study July 13, 2015 Martha Garcia Add Your CommentsNew research suggests that two chemicals commonly used during the manufacture of plastic products may increase a person’s risk of developing high blood pressure.ย In a study published online last week by the medical journal Hypertension, researchers examined the safety of two common phthalates, di-isononyl phthalate (DINP) and di-isodecyl phthalate (DIDP), which are increasingly used as replacements for other plastic chemicals.Researchers found that individuals with higher metabolite levels of the two chemicals in their urine were more linked to higher blood pressure in children and adolescents. For every tenfold increase in the amount of phthalates consumed, there was a 1.1 millimeters of mercury increase in blood pressure.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONThe plastic chemicals DINP and DIDP are increasingly used as replacements for di-2-Ethylhexylphthalate. All three phthalates are associated with higher age, sex and height standardized blood pressure.The cross sectional analysis used data from the National Health and Nutrition Examination Survey conducted between 2009 to 2012. The study focused on a subsample of children and adolescents in the U.S. ranging in ages form 6 to 19.Researchers reviewed blood samples and urine analysis from 356 children and adolescents from the NHANES study which surveys 5,000 participants every year.The study found each unit increase in DINP metabolites a 0.105 deviation unit increase was found in systolic blood pressure. For each unit increase in DIDP metabolites a 0.113 standard deviation unit increase was found in systolic blood pressure.โOur research adds to growing concerns that environmental chemicals might be independent contributors to insulin resistance, elevated blood pressure and other metabolic disorders,โ says study lead investigator Leonardo Trasande, MD, an associate professor of pediatrics, environmental medicine, and population health at NYU Langone.Increased phthalate metabolites were not associated with higher triglycerides or high density lipoproteins (HDL).Phthalates are commonly found in cosmetics, personal care products, soap and are used in manufacturing to strengthen plastic wrap and processed food containers.This is the first study to examine the potential health risks from DEHP replacements, both DINP and DIDP.Another study revealed the association between both DINP and DIDP concentrations and increase insulin resistance, which is a precursor to diabetes. One in three adolescents with the highest DINP levels also had the highest insulin resistance. Those patients with the lowest concentration, only one in four, had insulin resistance.The original phthalate chemical DEHP was used as a plasticizer but was banned in 2004 in Europe after a link was found between exposure and ill effects to human health. In the United States manufacturers voluntarily began to replace DEHP with DINP and DIDP over the last 10 years.Researchers warn people to limit their exposure to phthalates. Recommendations include not microwaving food in plastic containers or containers covered by plastic wrap, to wash plastic food containers by hand, and to avoid using plastic containers labeled on the bottom with the recycling numbers 3, 6, and 7.Another study published in 2014 called for the safe levels of BPA and other endocrine disrupting chemicals, like phthalates, to be reevaluated after rat studies revealed the animals respond differently to the chemicals than humans. This prompted researchers to reconsider prior safety conclusions drawn from animal studies.โOur study adds further concern for the need to test chemicals for toxicity prior to their broad and widespread use, which is not required under current federal law, the 1976 Toxic Substances Control Act,โ Trasande said. Written by: Martha GarciaHealth & Medical Research WriterMartha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Chemicals, Hypertension, Phthalates, PlasticMore Lawsuit Stories Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial September 9, 2026 Lawsuit Alleges Apple AirTag Tracked Vehicle Location for Months September 9, 2026 Chlorpyrifos Autism Link May Involve Immune, Inflammatory Gene Changes: Study September 9, 2026 0 Comments X/TwitterThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (Posted: today)The second Bard PowerPort lawsuit bellwether trial has ended in a $40 million verdict for the plaintiff who had the implant removed after the catheter broke and traveled to her heart.MORE ABOUT: BARD POWERPORT LAWSUITNearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (08/12/2026)Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026) Lawsuit Alleges Ozempic Caused Sudden Eyesight Loss (Posted: yesterday)An Ozempic NAION lawsuit blames the diabetes drug for a woman’s sudden loss of vision and alleges the manufacturer failed to warn doctors of the risks.MORE ABOUT: OZEMPIC LAWSUITOzempic NAION Lawsuit Filed Over Sudden, Permanent Vision Loss (08/03/2026)Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits (07/16/2026)Wegovy Vision Side Effects Resulted in Blindness in Left Eye, Lawsuit Alleges (06/16/2026) Boston Scientific Spinal Cord Stimulator Lead Recall Issued After More Than 1,000 Serious Injuries (Posted: 5 days ago)Certain Infinion CX spinal cord stimulator leads from Boston Scientific have been recalled after more than 1,000 serious injuries were linked to fractures that may disrupt stimulation and require additional surgery.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJudge Allows Back Stimulator Lawsuits Against Boston Scientific to Be Directly Filed in MDL (08/31/2026)Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026 (08/26/2026)Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (08/24/2026)
Jury Awards $40M Port Catheter Lawsuit Payout in Bard PowerPort Bellwether Trial (Posted: today)The second Bard PowerPort lawsuit bellwether trial has ended in a $40 million verdict for the plaintiff who had the implant removed after the catheter broke and traveled to her heart.MORE ABOUT: BARD POWERPORT LAWSUITNearly 4,000 Bard PowerPort Lawsuits Are Awaiting Outcome of Upcoming Bellwether Trials (08/12/2026)Bard PowerPort Lawyers Make Final Preparations for Next MDL Bellwether Trial (07/17/2026)New Trial Sought for First Bard PowerPort Bellwether Lawsuit (06/05/2026)
Lawsuit Alleges Ozempic Caused Sudden Eyesight Loss (Posted: yesterday)An Ozempic NAION lawsuit blames the diabetes drug for a woman’s sudden loss of vision and alleges the manufacturer failed to warn doctors of the risks.MORE ABOUT: OZEMPIC LAWSUITOzempic NAION Lawsuit Filed Over Sudden, Permanent Vision Loss (08/03/2026)Link Between NAION and Ozempic, Wegovy Will Be Focus of Early Discovery in GLP-1 Vision Loss Lawsuits (07/16/2026)Wegovy Vision Side Effects Resulted in Blindness in Left Eye, Lawsuit Alleges (06/16/2026)
Boston Scientific Spinal Cord Stimulator Lead Recall Issued After More Than 1,000 Serious Injuries (Posted: 5 days ago)Certain Infinion CX spinal cord stimulator leads from Boston Scientific have been recalled after more than 1,000 serious injuries were linked to fractures that may disrupt stimulation and require additional surgery.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJudge Allows Back Stimulator Lawsuits Against Boston Scientific to Be Directly Filed in MDL (08/31/2026)Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026 (08/26/2026)Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (08/24/2026)